Whitehawk Therapeutics, Inc. (WHWK) stock
WHWKNasdaqPharmaceutical PreparationsFiscal year ends December 31
$3.13+0.05 (+1.62%)
Close on Nov 18, 2026Market cap $178.44MP/E –Yield –
Whitehawk Therapeutics pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Whitehawk Therapeutics's pe ratio was 19.3× on Jan 30, 2026.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Jan 30, 2026 | 19.3× | +2.0 |
| 2025 | Dec 31, 2025 | 17.3× | – |
See a number that looks wrong?